Article info
PDFConsensus
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
- Correspondence to Professor Josef S Smolen, Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Waehringer Guertel 18–20, A-1090 Vienna, Austria; josef.smolen{at}wienkav.at
Citation
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Publication history
- Accepted January 10, 2011
- First published March 6, 2011.
Online issue publication
January 08, 2022
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Web Only Data
Files in this Data Supplement:
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl